Literature DB >> 11016303

Repair of cardiac defects through a shorter right lateral thoracotomy in children.

Y L Liu1, H J Zhang, H S Sun, S J Li, J Yan, J W Su, C T Yu.   

Abstract

BACKGROUND: Median sternotomy is a conventional approach for correction of cardiac defects for many years; however, the cosmetic result is poor. Therefore, right lateral thoracotomy was tested as an alternative procedure with a better cosmetic outcome.
METHODS: Between October 1994 and February 1999, 683 patients underwent correction of congenital cardiac malformations during a cardiopulmonary bypass through right lateral thoracotomy involving a shorter incision through the third or the fourth intercostal space. All of the patients were children. The average age was 3.26+/-1.67 years (range, 4 months to 7 years). The average weight was 13.59+/-4.37 kg (5 to 40). The patients had various cardiac defects and associated anomalies.
RESULTS: Only 2 patients died after operation, 1 from low cardiac output and the other from severe pulmonary infection. The hospital morbidity was lower. The mean cardiopulmonary bypass time was 58.67+/-35.11 minutes (range, 16 to 430 minutes), the mean aortic cross-clamping time was 35.03+/-24.84 minutes (range, 3 to 205 minutes). The postoperative average mechanical ventilation time was 19.23+/-39.11 hours (range, 2 to 391 hours), and the mean postoperative stay was 8.55+/-12.54 days (range, 5 to 293 days).
CONCLUSIONS: The right lateral thoracotomy incision is a safe and effective alternative to a median sternotomy for correction of cardiac defects. Advantages of this approach compared with median sternotomy are less injury, maintenance of the continuity and the integrity of the bony thorax, and prevention of the development of "pigeon-chesting." The scar is less visible, hence, the cosmetic result can meet patient expectations. This procedure is consistent with the idea of minimal invasive surgery.

Entities:  

Mesh:

Year:  2000        PMID: 11016303     DOI: 10.1016/s0003-4975(00)01407-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Transfemoral Device Occlusion and Minimally Invasive Surgical Repair for Doubly Committed Subarterial Ventricular Septal Defects.

Authors:  Zhao Yang Chen; Yuan Ji Ma; Wen Zhi Pan; Qiang Chen; Wan Hua Chen; Chang Xiong; Lin Fan; Liang-Long Chen; Jun Bo Ge
Journal:  Pediatr Cardiol       Date:  2015-06-02       Impact factor: 1.655

2.  Comparison of effectiveness and cost between perventricular device occlusion and minimally invasive surgical repair for perimembranous ventricular septal defect.

Authors:  Yu Kun Luo; Wan Hua Chen; Chang Xiong; Chuan Chuan Li; Liang Long Chen
Journal:  Pediatr Cardiol       Date:  2014-08-22       Impact factor: 1.655

3.  Anterolateral minithoracotomies for the radical correction of congenital heart diseases.

Authors:  Gaetano Palma; Raffaele Giordano; Veronica Russolillo; Sabato Cioffi; Sergio Palumbo; Marco Mucerino; Vincenzo Poli; Giuseppina Langella; Carlo Vosa
Journal:  Tex Heart Inst J       Date:  2009

Review 4.  Anterolateral minithoracotomy versus median sternotomy for the treatment of congenital heart defects: a meta-analysis and systematic review.

Authors:  Chao Ding; Chunmao Wang; Aiqiang Dong; Minjian Kong; Daming Jiang; Kaiyu Tao; Zhonghua Shen
Journal:  J Cardiothorac Surg       Date:  2012-05-04       Impact factor: 1.637

5.  Individualized strategy of minimally invasive cardiac surgery in congenital cardiac septal defects.

Authors:  Jiaquan Zhu; Yunjiao Zhang; Chunrong Bao; Fangbao Ding; Ju Mei
Journal:  J Cardiothorac Surg       Date:  2022-01-15       Impact factor: 1.637

6.  Minimally invasive approaches to atrial septal defect closure.

Authors:  Igor E Konstantinov; Yasuhiro Kotani; Edward Buratto; Antonia Schulz; Yaroslav Ivanov
Journal:  JTCVS Tech       Date:  2022-04-02

7.  Letter to the editor on "Early and Mid-Term Outcome of Pediatric Congenital Mitral Valve Surgery".

Authors:  Cristina Barbero; Mauro Rinaldi
Journal:  Res Cardiovasc Med       Date:  2016-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.